Pfizer has joined Accelrys consortium
Pfizer has joined the Accelrys Enterprise Cheminformatics Consortium – a collaborative project to develop cheminformatics software components and services for commercial companies.
Mark Emkjer, president and CEO of Accelrys, explained the importance of such a collaboration: ‘Close partnership and collaboration with industry is essential for Accelrys to develop software and services that help solve critical research problems.’
This is the latest in a long line of successful consortia led by Accelrys, which have worked in areas such as catalysis, combinatorial chemistry and nanotechnology. Consortium members collaborate in directing research and development activities to solve business issues, and have exclusive use of the resulting products for some time afterwards.